India biosimilars guidelines

Will the new Indian biosimilars guidelines streamline the process for drug approvals?

Current Voting

76%

13%

11%

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X